173 related articles for article (PubMed ID: 2325821)
1. The effect of selective noradrenergic denervation on thyrotropin secretion in the rat.
Jaffer A; Searson A; Russell VA; Taljaard JJ
Neurochem Res; 1990 Jan; 15(1):13-6. PubMed ID: 2325821
[TBL] [Abstract][Full Text] [Related]
2. The effect of partial noradrenergic denervation on corticosterone secretion in the rat.
Daniels WM; Jaffer A; Searson A; Russell VA; Taljaard JJ
Neurochem Res; 1989 Dec; 14(12):1187-90. PubMed ID: 2628787
[TBL] [Abstract][Full Text] [Related]
3. Effects of alpha 2- and beta-adrenoceptor agonists on growth hormone secretion following lesion of the noradrenergic system of the rat.
Jaffer A; Daniels WM; Russell VA; Taljaard JJ
Neurochem Res; 1992 Dec; 17(12):1255-60. PubMed ID: 1361032
[TBL] [Abstract][Full Text] [Related]
4. The effect of medial forebrain bundle lesion on thyrotropin secretion in the rat.
Jaffer A; Daniels WM; Russell VA; Taljaard JJ
Neurochem Res; 1991 May; 16(5):577-81. PubMed ID: 1754034
[TBL] [Abstract][Full Text] [Related]
5. Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.
Prieto M; Giralt MT
Pharmacol Toxicol; 2001 Mar; 88(3):152-8. PubMed ID: 11245411
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Srinivasan J; Schmidt WJ
Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
Szot P; Miguelez C; White SS; Franklin A; Sikkema C; Wilkinson CW; Ugedo L; Raskind MA
Neuroscience; 2010 Mar; 166(1):279-91. PubMed ID: 20045445
[TBL] [Abstract][Full Text] [Related]
8. DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action.
Ross SB; Stenfors C
Neurotox Res; 2015 Jan; 27(1):15-30. PubMed ID: 24964753
[TBL] [Abstract][Full Text] [Related]
9. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
Fritschy JM; Grzanna R
Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
[TBL] [Abstract][Full Text] [Related]
10. Noradrenaline and dopamine interaction in rat brain during development.
Ponzio F; Hallman H; Jonsson G
Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
Fritschy JM; Grzanna R
Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
[TBL] [Abstract][Full Text] [Related]
12. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
Jonsson G; Hallman H; Sundström E
Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
[TBL] [Abstract][Full Text] [Related]
13. Effect of VA-045 on central noradrenergic neuronal system in rats.
Okuyama S; Yamada S; Ogawa S; Kawashima N; Tomisawa K; Shima K; Kamata K
Gen Pharmacol; 1996 Sep; 27(6):1013-7. PubMed ID: 8909984
[TBL] [Abstract][Full Text] [Related]
14. The effect of selective noradrenergic lesions upon the stimulation by noradrenaline of inositol phospholipid breakdown in rat hippocampal miniprisms.
Fowler CJ; Magnusson O; Mohammed AK; Danysz W; Archer T
Eur J Pharmacol; 1986 Apr; 123(3):401-7. PubMed ID: 3087760
[TBL] [Abstract][Full Text] [Related]
15. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
[TBL] [Abstract][Full Text] [Related]
16. Evidence that 3,3',5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport.
Gordon JT; Kaminski DM; Rozanov CB; Dratman MB
Neuroscience; 1999; 93(3):943-54. PubMed ID: 10473259
[TBL] [Abstract][Full Text] [Related]
17. Effect of selective noradrenergic denervation on noradrenaline content and [3H]dopamine release in rat nucleus accumbens slices.
Russell VA; Lamm MC; Allin R; de Villiers AS; Searson A; Taljaard JJ
Neurochem Res; 1989 Feb; 14(2):169-72. PubMed ID: 2725817
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450.
Bromek E; Wójcikowski J; Daniel WA
Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135
[TBL] [Abstract][Full Text] [Related]
19. Noradrenaline is crucial for the substantia nigra dopaminergic cell maintenance.
Af Bjerkén S; Stenmark Persson R; Barkander A; Karalija N; Pelegrina-Hidalgo N; Gerhardt GA; Virel A; Strömberg I
Neurochem Int; 2019 Dec; 131():104551. PubMed ID: 31542295
[TBL] [Abstract][Full Text] [Related]
20. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.
Jonsson G; Hallman H; Ponzio F; Ross S
Eur J Pharmacol; 1981 Jun; 72(2-3):173-88. PubMed ID: 6265244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
